drugset
drugset / Trial / NCT00901693

An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis

NCT00901693 ↗

Phase 2 Terminated 452 enrolled Alcon Research
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of AL-46383A Ophthalmic Solution for the treatment of adenoviral conjunctivitis.

Timeline

Start
2009-06
Primary completion
2010-07
Completion
2010-07

Outcome

Outcome not reported

Stopped (Business): “Internal business decision”

Drugs

EvaluationDrugModalityDoseRoute
Subject AL-46383A Unknown — —

Indications

viral conjunctivitis